Viewing StudyNCT00074204



Ignite Creation Date: 2024-05-05 @ 11:32 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00074204
Status: COMPLETED
Last Update Posted: 2010-08-16
First Post: 2003-12-10

Brief Title: Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor: Case Comprehensive Cancer Center
Organization: Case Comprehensive Cancer Center

Organization Data

Organization: Case Comprehensive Cancer Center
Class: OTHER
Study ID: LILY1503
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Case Comprehensive Cancer Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Nathan Levitan MD
Old Organization: Ireland Cancer Center at University Hospitals Case Medical Center Case Comprehensive Cancer Center

Collaborators

Name Class
National Cancer Institute NCI NIH